| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $6,865,889 ) |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG079952 | A randomized, double-blind, placebo-controlled, clinical trial of a probiotic/prebiotic supplement for the dietary management of age-related bone loss. | 001 | 3 | NIH | 6/13/2025 | $52,670 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K24AG073527 | Mid-Career Mentoring Award For Patient-Oriented Research in Frailty and Health Outcomes | 000 | 4 | NIH | 9/8/2025 | $172,477 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG065265 | Determinants and Outcomes of Age-related Muscle Loss | 001 | 5 | NIH | 8/25/2025 | $0 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG065265 | Determinants and Outcomes of Age-related Muscle Loss | 000 | 5 | NIH | 7/14/2025 | $631,107 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K23HL151903 | Risk-Guided Atrial Fibrillation Surveillance in Ischemic Stroke | 004 | 5 | NIH | 7/4/2025 | $161,743 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG081349 | Long-term home-based transcranial electrical stimulation for cognitive and motor function in older adults with an increased risk of dementia: a randomized controlled trial | 001 | 2 | NIH | 8/21/2025 | $334,973 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG081349 | Long-term home-based transcranial electrical stimulation for cognitive and motor function in older adults with an increased risk of dementia: a randomized controlled trial | 002 | 2 | NIH | 9/5/2025 | $334,973 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG081349 | Long-term home-based transcranial electrical stimulation for cognitive and motor function in older adults with an increased risk of dementia: a randomized controlled trial | 002 | 2 | NIH | 9/5/2025 | -$334,973 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG081349 | Long-term home-based transcranial electrical stimulation for cognitive and motor function in older adults with an increased risk of dementia: a randomized controlled trial | 000 | 2 | NIH | 8/6/2025 | $561,198 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01HL175560 | Utilization and Clinical Outcomes of Left Atrial Appendage Occlusion in Older Adults with Atrial Fibrillation and Frailty | 001 | 2 | NIH | 7/1/2025 | $72,276 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01HL175560 | Utilization and Clinical Outcomes of Left Atrial Appendage Occlusion in Older Adults with Atrial Fibrillation and Frailty | 000 | 2 | NIH | 3/31/2025 | $650,478 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | 90EJIG0052 | Enhancing Elder Shelter with APS Collaboration, Trauma-Informed Housing Services, and Person-Led Goal-Setting | 00 | 2 | ACL | 6/24/2025 | $497,650 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K76AG095045 | Strengthening Recovery - Integrating Intrinsic Capacity Care into Post-Acute Skilled Nursing Facilities | 000 | 1 | NIH | 9/10/2025 | $243,000 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R33AG071744 | NIDUS II: Advanced-Stage Development and Utilization of the NIDUS Research Infrastructure to Advance Interdisciplinary Aging Research in Delirium | 002 | 5 | NIH | 9/8/2025 | $0 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R33AG071744 | NIDUS II: Advanced-Stage Development and Utilization of the NIDUS Research Infrastructure to Advance Interdisciplinary Aging Research in Delirium | 001 | 5 | NIH | 8/25/2025 | $64,075 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R33AG071744 | NIDUS II: Advanced-Stage Development and Utilization of the NIDUS Research Infrastructure to Advance Interdisciplinary Aging Research in Delirium | 000 | 5 | NIH | 3/7/2025 | $720,835 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AR041398 | Novel Molecular Biomarkers of Bone Microarchitecture | 000 | 30 | NIH | 3/13/2025 | $636,087 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R37AG032982 | Trial to Reduce Antimicrobial Use in Nursing home residents with Alzheimer's disease and other Dementias (TRAIN-AD) | 000 | 13 | NIH | 12/20/2024 | $711,507 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R37AG032982 | Trial to Reduce Antimicrobial Use in Nursing home residents with Alzheimer's disease and other Dementias (TRAIN-AD) | 001 | 13 | NIH | 7/22/2025 | $63,245 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K01AG083059 | The Effect of the Home Environment on Health and Wellbeing of Low-income Older Adults | 000 | 2 | NIH | 8/20/2025 | $124,875 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K24AG070106 | Mentoring Patient-Oriented Research to Prevent Injury in Older Adults | 000 | 5 | NIH | 5/29/2025 | $120,823 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG065299 | Vascular Mechanisms Underlying Skeletal Fragility in Older Adults | 001 | 5 | NIH | 8/21/2025 | $51,789 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG065299 | Vascular Mechanisms Underlying Skeletal Fragility in Older Adults | 000 | 5 | NIH | 11/27/2024 | $582,625 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K01AG075180 | Cortical mechanisms and modulation of somatosensation in older adults with foot sole somatosensory impairments | 000 | 4 | NIH | 1/13/2025 | $124,874 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG071809 | Applications of Claims-Based Frailty Index to Advance Evidence for Frailty-Guided Decision-Making | 000 | 5 | NIH | 8/14/2025 | $612,933 |
| | 2025 | 2025 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG079952 | A randomized, double-blind, placebo-controlled, clinical trial of a probiotic/prebiotic supplement for the dietary management of age-related bone loss. | 000 | 3 | NIH | 4/2/2025 | $592,527 |
| | 2025 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K23HL151903 | Risk-Guided Atrial Fibrillation Surveillance in Ischemic Stroke | 003 | 4 | NIH | 6/4/2025 | $0 |
| | 2025 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K23HL151903 | Risk-Guided Atrial Fibrillation Surveillance in Ischemic Stroke | 002 | 4 | NIH | 4/2/2025 | $0 |
| | 2025 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | T32AG023480 | Harvard Translational Research in Aging Training Program | 002 | 19 | NIH | 9/9/2025 | -$582,206 |
| | 2025 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | T32AG023480 | Harvard Translational Research in Aging Training Program | 000 | 19 | NIH | 4/24/2025 | $0 |
| | 2025 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | T32AG023480 | Harvard Translational Research in Aging Training Program | 001 | 19 | NIH | 5/27/2025 | $0 |
| | 2025 | 2023 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R03AG078894 | Predicting and Identifying Risk Factors for Short Time at Home in Older Adults after Hospitalization | 000 | 2 | NIH | 8/4/2025 | $0 |
| | 2025 | 2023 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K23HL151903 | Risk-Guided Atrial Fibrillation Surveillance in Ischemic Stroke | 001 | 3 | NIH | 1/23/2025 | $87,112 |
| | 2025 | 2023 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AR075346 | The Mechanistic Effects of Combined Testosterone Therapy and Exercise on Axial Bone and Muscle Post-Hip Fracture | 000 | 3 | NIH | 1/7/2025 | -$35,891 |
| | 2025 | 2023 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R03AG075434 | Effect of baseline and intercurrent medical factors on 6-year cognitive trajectory: Secondary analysis of the SAGES Study | 000 | 2 | NIH | 5/5/2025 | -$988 |
| | 2025 | 2022 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG059089 | Personalized brain activity modulation to improve balance and cognition in elderly fallers | 000 | 5 | NIH | 12/30/2024 | $0 |
| | 2025 | 2022 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | P01AG031720 | Delirium, Dementia, and the Vulnerable Brain: An Integrative Approach | 000 | 10 | NIH | 8/20/2025 | -$166,125 |
| | 2025 | 2022 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | P01AG031720 | Delirium, Dementia, and the Vulnerable Brain: An Integrative Approach | 000 | 10 | NIH | 8/20/2025 | -$9,582 |
| | 2025 | 2021 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AR061445 | The Gut Microbiome and Bone Microarchitecture | 000 | 9 | NIH | 10/29/2024 | $0 |
| | 2025 | 2019 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | RF1AG061221 | Safe Cardiometabolic Drug Prescribing to Prevent Injury in Nursing Home Residents | 000 | 1 | NIH | 10/1/2024 | -$210,198 |
|
| Issue Date FY: 2024 ( Subtotal = $11,513,518 ) (Continued on the next page) |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K01AG075180 | Cortical mechanisms and modulation of somatosensation in older adults with foot sole somatosensory impairments | 000 | 3 | NIH | 1/23/2024 | $124,874 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K23AG066929 | Intensive Palliative Care: Improving the Process of Palliative Ventilator Withdrawal Among Critically Ill Older Adults | 001 | 5 | NIH | 4/17/2024 | $194,400 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R33AG071744 | NIDUS II: Advanced-Stage Development and Utilization of the NIDUS Research Infrastructure to Advance Interdisciplinary Aging Research in Delirium | 000 | 4 | NIH | 2/16/2024 | $724,862 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R33AG071744 | NIDUS II: Advanced-Stage Development and Utilization of the NIDUS Research Infrastructure to Advance Interdisciplinary Aging Research in Delirium | 001 | 4 | NIH | 6/28/2024 | $80,540 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AR041398 | Novel Molecular Biomarkers of Bone Microarchitecture | 001 | 29 | NIH | 6/13/2024 | $48,536 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AR041398 | Novel Molecular Biomarkers of Bone Microarchitecture | 000 | 29 | NIH | 4/10/2024 | $624,051 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R37AG032982 | Trial to Reduce Antimicrobial Use in Nursing home residents with Alzheimer's disease and other Dementias (TRAIN-AD) | 001 | 12 | NIH | 5/6/2024 | $81,016 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R37AG032982 | Trial to Reduce Antimicrobial Use in Nursing home residents with Alzheimer's disease and other Dementias (TRAIN-AD) | 000 | 12 | NIH | 12/14/2023 | $729,130 |
|
